Ultima Genomics is revolutionizing the genomics industry with its new sequencing architecture. The company is dedicated to continuously driving the scale of omics information to enable unprecedented advances in biology and improvements in human health.
At Ultima Genomics, the mission is to reduce the cost of sequencing and increase accessibility, enabling data-driven healthcare and transformative biological research. Their innovative UG200 Series platform offers greater capacity, flexibility, and efficiency, with outputs of 20B, 10B, and 5B wafer reads, enabling more than 60,000 genomes per year on the UG200 Ultra.
The company supports a broad range of applications including whole genome sequencing, oncology, single-cell sequencing, proteomics, and methylation profiling. Ultima’s technology integrates seamlessly with existing lab automation and delivers improved variant calling accuracy and coverage uniformity across complex regions of the genome.